Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
64.39
+2.04 (3.27%)
At close: Jun 17, 2026, 4:00 PM EDT
64.55
+0.16 (0.24%)
After-hours: Jun 17, 2026, 5:43 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $431.33 million as of June 17, 2026. Its market cap has increased by 119.67% in one year.
Market Cap
431.33M
Enterprise Value
294.07M
1-Year Change
119.67%
Ranking
Category
Stock Price
$64.39
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $431.33M, an increase of 56.19%. That is a compound annual growth rate of 7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 431.33M | -1.15% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 440.47M |
| Prothena Corporation | 434.01M |
| Artiva Biotherapeutics | 432.92M |
| C4 Therapeutics | 424.58M |
| Indaptus Therapeutics | 421.26M |
| Forte Biosciences | 420.90M |
| Prelude Therapeutics | 416.55M |
| Adlai Nortye | 402.00M |